Shanghai Aladdin Biochemical TechnologyLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Shanghai Aladdin Biochemical TechnologyLtd heeft een totaal eigen vermogen van CN¥1.1B en een totale schuld van CN¥409.6M, wat de schuld-eigenvermogensverhouding op 36.9% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥1.7B en CN¥616.9M. De EBIT Shanghai Aladdin Biochemical TechnologyLtd is CN¥138.6M waardoor de rentedekking 97.3 is. Het heeft contanten en kortetermijnbeleggingen van CN¥539.1M.

Belangrijke informatie

36.9%

Verhouding schuld/eigen vermogen

CN¥409.64m

Schuld

Rente dekkingsratio	97.3x
Contant	CN¥539.11m
Aandelen	CN¥1.11b
Totaal verplichtingen	CN¥616.91m
Totaal activa	CN¥1.73b

Recente financiële gezondheidsupdates

Does Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Have A Healthy Balance Sheet?

Nov 19

Recent updates

Does Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Have A Healthy Balance Sheet?

Nov 19

Estimating The Fair Value Of Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)

Oct 16

What Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) 34% Share Price Gain Is Not Telling You

Sep 30

Here's What's Concerning About Shanghai Aladdin Biochemical TechnologyLtd's (SHSE:688179) Returns On Capital

Sep 28

Cautious Investors Not Rewarding Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) Performance Completely

Jun 06

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Apr 23

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥1.2B ) 688179 } overtreffen de korte termijn passiva ( CN¥209.1M ).

Langlopende schulden: De kortetermijnactiva 688179 ( CN¥1.2B ) overtreffen de langetermijnschulden ( CN¥407.8M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 688179 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 688179 is de afgelopen 5 jaar gestegen van 1.3% naar 36.9%.

Schuldendekking: De schuld van 688179 wordt goed gedekt door de operationele kasstroom ( 34.6% ).

Rentedekking: De rentebetalingen op de schuld van 688179 worden goed gedekt door EBIT ( 97.3 x dekking).

Shanghai Aladdin Biochemical TechnologyLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Have A Healthy Balance Sheet?

Recent updates

Does Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Have A Healthy Balance Sheet?

Third quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.085 in 3Q 2023)

Estimating The Fair Value Of Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)

Investor sentiment deteriorates as stock falls 18%

What Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) 34% Share Price Gain Is Not Telling You

New minor risk - Share price stability

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Here's What's Concerning About Shanghai Aladdin Biochemical TechnologyLtd's (SHSE:688179) Returns On Capital

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.053 in 2Q 2023)

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179) announces an Equity Buyback for CNY 15 million worth of its shares.

Cautious Investors Not Rewarding Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) Performance Completely

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.086 in 1Q 2023)

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Shanghai Aladdin Biochemical Technology Co.,Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.074 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.074 (vs CN¥0.099 in 2Q 2022)

Investor sentiment deteriorates as stock falls 29%

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.22 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.67 (vs CN¥0.64 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.15 in 2Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.20 in 1Q 2021)

Full year 2021 earnings released: EPS: CN¥0.89 (vs CN¥0.93 in FY 2020)

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.21 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.93 (vs CN¥0.84 in FY 2019)

New 90-day high: CN¥106

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven